Gene Network Sciences employs massively parallel supercomputers to probe vast amounts of raw human biological data, discovering new insights into the biological causes of human disease -- and new opportunities for diagnosis and treatment. Learn more
12/14/09 — "Drug discovery paradigm could shift with cancer center involvement" by GNS's Tom Neyarapally, is published in Drug and Discovery News in December 2009. > Read More
12/10/09 — Fina Technologies, a subsidiary of GNS, announces the successful completion a $4.5M Series A Financing. > Read More
10/22/09 — The New York State Foundation for Science, Technology and Innovation (NYSTAR) names CEO Colin Hill to its Board of Directors. > Read More
1/10/10 — The Potential of Biologic Network Models in Understanding the Etiopathogenesis of Ovarian Cancer" by GNS's Iya Khalil and Tom Neyarapally and UCONN's Drs. Brewer and Runowicz, appears in Gynecologic Oncology (Epub 11/18/09) > Read More
9/27/09 — A paper entitled "Customized care 2020: How Medical Sequencing and Network Biology Will Enable Personalized Medicine," by Colin Hill and GNS SAB's Dr. Mark Boguski, is published in Faculty of 1000 Biology. > Read More